tiprankstipranks
APONTIS PHARMA AG (DE:APPH)
XETRA:APPH
Germany Market

APONTIS PHARMA AG (APPH) Stock Forecast & Price Target

4 Followers
See the Price Targets and Ratings of:

APPH Analyst Ratings

Currently, no data available
Based on 0 analysts giving stock ratings to
APONTIS
PHARMA AG
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

APPH Stock 12 Month Forecast

There Are No Analyst Ratings for DE:APPH In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

APPH Financial Forecast

APPH Earnings Forecast

Currently, no earnings data available.
Currently, no earnings data available.

APPH Sales Forecast

Next quarter’s sales forecast for APPH is €9.80M with a range of €9.80M to €9.80M. The previous quarter’s sales results were ―. APPH beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 56.45% of the time in the same period. In the last calendar year APPH has Outperformed its overall industry.
Next quarter’s sales forecast for APPH is €9.80M with a range of €9.80M to €9.80M. The previous quarter’s sales results were ―. APPH beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 56.45% of the time in the same period. In the last calendar year APPH has Outperformed its overall industry.

Detailed List of Analyst Forecasts​

Analyst Performance
Any
Any
Analyst Rating
Any
Any
Upside / Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Warburg Research
€18€20
Buy
127.79%
Upside
Reiterated
04/12/24
Analysts Offer Insights on Healthcare Companies: APONTIS PHARMA AG (XETRA: DE:APPH), Roche Holding AG (Other OTC: RHHVF) and Zur Rose Group AG (Six Swiss: CH:DOCM)

Best Analysts Covering APONTIS PHARMA AG

Which Analyst Should I Follow If I Want to Buy DE:APPH and Sell After:
1 Month
xxx
Success Rate
6/12 ratings generated profit
50%
Average Return
+3.64%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 50.00% of your transactions generating a profit, with an average return of +3.64% per trade.
3 Months
xxx
Success Rate
6/12 ratings generated profit
50%
Average Return
+5.78%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +5.78% per trade.
1 Year
Christian EhmannWarburg Research
Success Rate
7/12 ratings generated profit
58%
Average Return
+14.03%
reiterated a buy rating 3 months ago
Copying Christian Ehmann's trades and holding each position for 1 Year would result in 58.33% of your transactions generating a profit, with an average return of +14.03% per trade.
2 Years
xxx
Success Rate
7/12 ratings generated profit
58%
Average Return
+18.69%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 58.33% of your transactions generating a profit, with an average return of +18.69% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

APPH Analyst Recommendation Trends

Rating
Aug 23
Nov 23
Jan 24
Feb 24
Apr 24
Strong Buy
4
4
3
3
3
Buy
0
0
0
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
4
4
3
3
3
In the current month, APPH has received 3 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. APPH average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

APPH Stock Forecast FAQ

What is DE:APPH’s average 12-month price target, according to analysts?
Currently, no data Available
What is DE:APPH’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for DE:APPH, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is APONTIS PHARMA AG a Buy, Sell or Hold?
      Currently, no data Available
      What is APONTIS PHARMA AG’s share price target?
      Currently, no data Available
      What do analysts say about APONTIS PHARMA AG?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of APONTIS PHARMA AG?
      To buy shares of DE:APPH, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis